as on December 13, 2025 at 2:29 am IST
Day's Low
Day's High
2.77%
Downside
0.42%
Upside
52 Week's Low
52 Week's High
49.03%
Downside
3.18%
Upside
Check Axsome Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$7.5B
EPS (TTM)
-3.8577
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-13.72
Industry PE ratio
8.214070796460177
PEG Ratio
0EBITDA
-187.9M
Revenue (TTM)
561.3M
Profit Margin
-40.90%
Return On Equity TTM
-275.50%
Track how Axsome Therapeutics, Inc. P/E has moved over time to understand its valuation trends.
Axsome Therapeutics, Inc. in the last 5 years
Lowest (-30.23x)
September 30, 2025
Today (-13.72x)
December 12, 2025
Industry (8.21x)
December 12, 2025
Highest (-8.02x)
June 30, 2022
Today’s Price to Earnings Ratio: -13.72x
Compare market cap, revenue, PE, and other key metrics of Axsome Therapeutics, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $7.5B | 87.53% | -13.72 | -40.90% | |
| BUY | $41.6B | 389.45% | -16.34 | -264.83% | |
| BUY | $53.4B | 218.26% | 1444.5 | 1.36% | |
| BUY | $114.0B | 98.92% | 31.25 | 31.35% | |
| BUY | $77.0B | 55.66% | 17.42 | 32.13% |
The Axsome Therapeutics, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Axsome Therapeutics, Inc. investment value today
Current value as on today
₹1,63,636
Returns
₹63,636
(+63.64%)
Returns from Axsome Therapeutics, Inc. Stock
₹57,073 (+57.07%)
Dollar Returns*
₹6,563 (+6.56%)
Based on 22 analysts
90.91%
Buy
9.09%
Hold
0.00%
Sell
Based on 22 analysts, 90.91% of analysts recommend a 'BUY' rating for Axsome Therapeutics, Inc.. Average target price of $179.74
Get share price movements and forecasts by analysts on Axsome Therapeutics, Inc..
What analysts predicted
17.53%UPSIDE
Target Price
$179.74
Current Price
$148.23
Analyzed by
22 Analysts
Target
$179.74
Axsome Therapeutics, Inc. target price $179.74, a slight upside of 17.53% compared to current price of $148.23. According to 22 analysts rating.
Search interest for Axsome Therapeutics, Inc. Stock has increased by 20% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:20% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 4 quarters, -74.91M → -47.22M (in $), with an average increase of 17.2% per quarter
Price Rise
![]()
In the last 3 months, AXSM stock has moved up by 25.6%
Revenue Rich
![]()
Revenue is up for the last 10 quarters, 46.7M → 170.99M (in $), with an average increase of 13.2% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 908.0% return, outperforming this stock by 820.6%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 171.0% return, outperforming this stock by 113.4%
| Organisation | Axsome Therapeutics, Inc. |
| Headquarters | One World Trade Center, New York, NY, United States, 10007 |
| Industry | Health Technology |
| CEO | Dr. Herriot Tabuteau M.D. |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Mark L. Jacobson M.A. | Chief Operating Officer |
Mr. Hunter Murdock Esq. | General Counsel & Secretary |
Mr. Ari Maizel | Chief Commercial Officer |
Darren Opland | Director of Corporate Communications |
Dr. Herriot Tabuteau M.D. | Founder, Chairman, CEO & President |
Mr. Nick Pizzie CPA, M.B.A. | Chief Financial Officer |
Axsome Therapeutics, Inc. share price today is $148.23 as on at the close of the market. Axsome Therapeutics, Inc. share today touched a day high of $148.85 and a low of $144.13.
Axsome Therapeutics, Inc. share touched a 52 week high of $152.94 on and a 52 week low of $75.56 on . Axsome Therapeutics, Inc. stock price today i.e. is closed at $148.23,which is 3.08% down from its 52 week high and 96.18% up from its 52 week low.
Axsome Therapeutics, Inc. market capitalisation is $0.01T as on .
Indian investors can start investing in Axsome Therapeutics, Inc. (AXSM) shares with as little as ₹90.397 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹903.97 in Axsome Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Axsome Therapeutics, Inc. share’s latest price of $148.23 as on December 13, 2025 at 2:29 am IST, you will get 0.0675 shares of Axsome Therapeutics, Inc.. Learn more about
fractional shares .
Axsome Therapeutics, Inc. stock has given 87.53% share price returns and 22.1% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?